Zydus's Sugammadex Injection indicated for the reversal of neuromuscular blockade gets final approval from USFDA.
Read More
U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Sun Pharma's deuruxolitinib, an investigational oral selective inhibitor of Janus kinases JAK1 and JAK2, for the treatment of adults with moderate to severe alopecia areata.
Read More
India's drug regulator has found that a cough syrup and an anti-allergy syrup made by Norris Medicines are toxic, according to a government report, months after Indian-made cough syrups were linked to 141 children's deaths worldwide
Read More
EET tablets belong to a class of medication known as antiretrovirals and this fixed-dose triple-drug combination medication is indicated for treatment of HIV-1 infection in adult patients weighing at least 40kgs. The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Atripla Tablets of Gilead Sciences LLC.
Read More
Icosapent Ethyl Capsules can be used as a dietary adjunct for lowering triglyceride (TG) levels in adult patients with severe hypertriglyceridemia
Read More
SigTuple’s AI100 with Shonit is AI-assisted digital pathology, wherein a physical sample is digitally imaged through a microscopic lens and the AI models extract each cell and then classify it into over 30 different cell types
Read More
U.S. Food and Drug Administration granted novel market authorisation for Invitae Common Hereditary Cancers Panel.
Read More
The National Pharmaceutical Pricing Authority (NPPA) has established ceiling prices for 51 drug formulations, including medications such as Sitagliptin, Pioglitazone, and Metformin Hydrochloride (Sustained Released) Tablets used in the management of type 2 diabetes mellitus.
Read More
